Skip to content
Organon
-
Sun Pharma receives Organon shareholder approval for US$11.75B acquisition
Sun Pharma disclosed the development in an exchange filing, confirming that Organon stockholders had voted in favour of the proposals required to advance the proposed merger transaction.
-
Sun Pharma to acquire Organon for US$11.75B to dominate global women’s health
The acquisition is expected to strengthen Sun Pharma’s global footprint while broadening its presence in women’s health, biosimilars, and established medicines.